dc.contributor.author | Ucero Lozano, R. | |
dc.contributor.author | Pérez Llanes, R. | |
dc.contributor.author | Cuesta Barriuso, Rubén | |
dc.contributor.author | Donoso Úbeda, E. | |
dc.date.accessioned | 2025-03-14T08:50:43Z | |
dc.date.available | 2025-03-14T08:50:43Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Pharmaceuticals, 17(7), (2024); doi:10.3390/ph17070835 | |
dc.identifier.issn | 1424-8247 | |
dc.identifier.uri | https://hdl.handle.net/10651/77575 | |
dc.description.sponsorship | Swedish Orphan Biovitrum S.L USA | |
dc.language.iso | eng | |
dc.relation.ispartof | Pharmaceuticals | |
dc.rights | ©, | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85199870383&doi=10.3390%2fph17070835&partnerID=40&md5=0d14e5a16716e2fa08e0bcf64ec5e2fc | |
dc.title | Changes in quality of life, adherence, and kinesiophobia in patients with hemophilia treated with extended half-life treatment: final results of the longhest project | |
dc.type | journal article | |
dc.identifier.doi | 10.3390/ph17070835 | |
dc.relation.publisherversion | http://dx.doi.org/10.3390/ph17070835 | |